Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ØRE- NÆSE- HALSKLINIKKEN I GREVE ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.7% 0.7%   Bankruptcy risk   2.7% 2.9% 1.9% 2.5% 1.8% 2.1% 17.3% 17.1%   Credit score (0-100)   62 59 69 60 70 67 2 2   Credit rating   BB BB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.6 0.0 1.1 0.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,254 2,549 3,205 3,364 3,366 3,407 0.0 0.0   EBITDA   519 887 1,512 1,562 1,455 1,490 0.0 0.0   EBIT   434 800 1,462 1,503 1,382 1,461 0.0 0.0   Pre-tax profit (PTP)   455.9 794.5 1,466.2 1,504.6 1,370.3 1,412.3 0.0 0.0   Net earnings   341.2 619.1 1,143.2 1,173.4 1,069.0 1,103.1 0.0 0.0   Pre-tax profit without non-rec. items   456 794 1,466 1,505 1,370 1,412 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   89.5 177 150 218 145 116 0.0 0.0   Shareholders equity total   438 344 1,287 611 1,230 1,228 3.1 3.1   Interest-bearing liabilities   1.6 297 0.0 112 53.4 0.0 0.0 0.0   Balance sheet total (assets)   1,114 1,299 1,996 1,362 1,849 1,873 3.1 3.1   Net Debt   -372 -245 -685 -414 -802 -29.5 -3.1 -3.1     See the entire balance sheet 1000.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,254 2,549 3,205 3,364 3,366 3,407 0.0 0.0   Gross profit growth   -7.6% 13.1% 25.7% 5.0% 0.0% 1.2% -100.0% 0.0%   Employees   0 3 3 4 0 0 0 0   Employee growth %   -100.0% 0.0% 0.0% 33.3% -100.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,114 1,299 1,996 1,362 1,849 1,873 3 3   Balance sheet change%   -43.9% 16.6% 53.6% -31.7% 35.7% 1.3% -99.8% 0.0%   Added value   519.0 886.9 1,511.6 1,561.7 1,440.8 1,490.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -171 -0 -77 9 -145 -58 -116 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   19.2% 31.4% 45.6% 44.7% 41.1% 42.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   29.8% 66.3% 89.1% 89.8% 86.1% 78.5% 0.0% 0.0%   ROI %   52.6% 148.0% 152.3% 150.1% 137.8% 116.4% 0.0% 0.0%   ROE %   41.2% 158.3% 140.2% 123.6% 116.2% 89.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   39.3% 26.5% 64.5% 44.8% 66.5% 65.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -71.8% -27.6% -45.3% -26.5% -55.1% -2.0% 0.0% 0.0%   Gearing %   0.4% 86.4% 0.0% 18.3% 4.3% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   12.6% 3.6% 1.5% 6.3% 14.4% 182.5% 0.0% 0.0%   1000.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   1.5 1.2 2.6 1.5 2.8 2.7 0.0 0.0   Current Ratio   1.5 1.2 2.6 1.5 2.8 2.7 0.0 0.0   Cash and cash equivalent   374.0 542.2 685.1 525.1 855.6 29.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   348.4 167.6 1,137.8 393.1 1,084.9 1,112.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 296 504 390 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 296 504 390 0 0 0 0   EBIT / employee   0 267 487 376 0 0 0 0   Net earnings / employee   0 206 381 293 0 0 0 0